The European Medicines Agency has decided to appeal against two interim decisions handed down by a European court in April that represent part of a legal challenge by AbbVie Inc and InterMune Inc to the agency’s transparency policy. ---Subscribe to MedNous to access this article--- Regulation & Policy
